Alpha Cognition Inc. (ACOG) stock
ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3060% above fair value
$7.83−0.47 (-5.66%)
Close on Nov 16, 2026Market cap $170.52MP/E –Yield –
Alpha Cognition total assets
Total assets on the balance sheet at the end of each period.
Alpha Cognition's total assets was $64.52M at Jun 30, 2026. For fiscal 2025 it was $79.73M, up 57.1% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $79.73M | +57.1% |
| FY2024 | Dec 31, 2024 | $50.74M | +1969.1% |
| FY2023 | Dec 31, 2023 | $2.45M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $64.52M | +43.0% |
| Q1 FY2026 | Mar 31, 2026 | $69.25M | +42.5% |
| Q4 FY2025 | Dec 31, 2025 | $79.73M | +57.1% |
| Q3 FY2025 | Sep 30, 2025 | $46.30M | +820.9% |
| Q2 FY2025 | Jun 30, 2025 | $45.12M | +2067.3% |
| Q1 FY2025 | Mar 31, 2025 | $48.61M | +1882.3% |
| Q4 FY2024 | Dec 31, 2024 | $50.74M | – |
| Q3 FY2024 | Sep 30, 2024 | $5.03M | – |
| Q2 FY2024 | Jun 30, 2024 | $2.08M | – |
| Q4 FY2023 | Dec 31, 2023 | $2.45M | – |
See a number that looks wrong?